Nu-Med Plus (NUMD) Accounts Payables (2012 - 2025)

Nu-Med Plus has disclosed Accounts Payables across 14 years of filings, most recently posting $48203.0 for Q4 2025.

• Accounts Payables for Q4 2025 came in at $48203.0, up 12.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $48203.0 (up 12.0% YoY), and the FY2025 annual result was $48203.0, up 12.0% from the prior year.
• Accounts Payables came in at $48203.0 for Q4 2025 at Nu-Med Plus, up from $47847.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $69378.0 in Q3 2022 to a low of $478.0 in Q4 2023.
• The 5-year median for Accounts Payables is $22925.0 (2021), against an average of $29245.9.
• Across the five-year window, Accounts Payables tumbled 93.35% in 2023 and jumped 8904.18% in 2024, its largest moves.
• Nu-Med Plus' Accounts Payables stood at $27744.0 in 2021, then slumped by 74.08% to $7192.0 in 2022, then sank by 93.35% to $478.0 in 2023, then surged by 8904.18% to $43040.0 in 2024, then increased by 12.0% to $48203.0 in 2025.
• The last three Accounts Payables figures came in at $48203.0 (Q4 2025), $47847.0 (Q3 2025), and $55204.0 (Q2 2025), per Business Quant data.